Close
ACHEMA MIDDLE EAST 2026

Allergan Issues Statement On Specialty Pharmacy Utilization

Company Does Not Rely On Specialty Pharmacies For The Distribution of Its Brand Products -- 97% of Allergan U.S. Branded Sales Are Distributed Through...

Expert Offers Car Seat Safety Tips

Although it can sometimes be a challenge to get a cranky, wriggling toddler into a child car seat, those safety devices can protect youngsters...

The 9th Asian & Oceanic epilepsy Congress

The 9th Asian & Oceanic epilepsy Congress was recently concluded in Manilla, Phillipines. In this conference UCB had brought together 4 key experts from...

Study Links Early Infections to Celiac Risk

Children who have a lot of infections in the first 18 months of life may have an increased risk for celiac disease, a new...

Higher-Volume Rehab Centers Better for Hip Fracture Recovery: Study

Seniors who break a hip receive the best care in skilled nursing facilities with the most experience handling such fractures, a new study suggests....

Keytruda Approved for Leading Form of Lung Cancer

Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced cases of the most common type of lung malignancy,...

ABBVIE ANNOUNCES SUBMISSION OF A SUPPLEMENTAL NEW DRUG APPLICATION FOR IMBRUVICA® (IBRUTINIB) FOR TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA

a global biopharmaceutical company, announced today that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) based...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...